Empagliflozin's Mortality Benefit Boosts PrescribingEmpagliflozin's Mortality Benefit Boosts Prescribing

A Medscape poll found that two-thirds of physicians are prescribing the diabetes drug to more patients following the discovery of a cardiac benefit in a landmark study last year. Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Alert Source Type: news